Ihab Eldessouki
Impact in
-
- Acute Myeloid Leukemia Research
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Mohamed Rahouma (6 shared papers)Nagla Abdel Karim (13 shared papers)John C. Morris (10 shared papers)Nagla Abdel Karim (1 shared paper)Mohamed Kamel (5 shared papers)Ahmed Abouarab (3 shared papers)Changchun Xie (3 shared papers)Adham Elmously (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (1 paper)Oncotarget (1 paper)Journal of Thoracic Oncology (1 paper)Journal of Oncology (1 paper)
- Partner nations
- United StatesEgyptItaly
In The Last Decade
Ihab Eldessouki
22 papers receiving 350 citations
Peers
Comparison fields: 5 of 50
- Hematology 50
- Oncology 115
- Cardiology and Cardiovascular Medicine 70
- Pulmonary and Respiratory Medicine 101
- Ophthalmology 19
Countries citing papers authored by Ihab Eldessouki
This map shows the geographic impact of Ihab Eldessouki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ihab Eldessouki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ihab Eldessouki more than expected).
Fields of papers citing papers by Ihab Eldessouki
This network shows the impact of papers produced by Ihab Eldessouki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ihab Eldessouki. The network helps show where Ihab Eldessouki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ihab Eldessouki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 71 | |
| 2 | 2019 | 58 | |
| 3 | 2018 | 45 | |
| 4 | 2017 | 43 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 14 | |
| 7 | 2017 | 14 | |
| 8 | 2018 | 12 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2018 | 7 | |
| 14 | 2017 | 7 | |
| 15 | 2019 | 5 | |
| 16 | 2021 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2015 | 1 |
About Ihab Eldessouki
Ihab Eldessouki is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Molecular Biology, having authored 23 papers that have together received 354 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (2 papers), Acute Myeloid Leukemia Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Autophagy in Disease and Therapy (2 papers) and Ocular Oncology and Treatments (2 papers). The work is most often cited by research in Hematology (50 citations), Oncology (115 citations), Cardiology and Cardiovascular Medicine (70 citations), Pulmonary and Respiratory Medicine (101 citations) and Ophthalmology (19 citations). Ihab Eldessouki has collaborated with scholars based in United States, Egypt and Italy. Frequent co-authors include Mohamed Rahouma, Nagla Abdel Karim, John C. Morris, Nagla Abdel Karim, Mohamed Kamel, Ahmed Abouarab, Changchun Xie, Adham Elmously, Massimo Baudo and Mario Gaudino. Their work appears in journals such as Journal of Clinical Oncology, Blood, Oncotarget, Journal of Thoracic Oncology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.